SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-005130
Filing Date
2016-05-02
Accepted
2016-05-02 17:17:03
Documents
45
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20160331x10q.htm 10-Q 923220
2 EX-10.1 mrns-20160331ex10121129e.htm EX-10.1 25351
3 EX-31.1 mrns-20160331ex31196d138.htm EX-31.1 16962
4 EX-31.2 mrns-20160331ex312e3b3bf.htm EX-31.2 16900
5 EX-32.1 mrns-20160331ex3218afb77.htm EX-32.1 10452
6 GRAPHIC mrns20160331x10q001.jpg GRAPHIC 23678
  Complete submission text file 0001558370-16-005130.txt   2649580

Data Files

Seq Description Document Type Size
7 EX-101.INS mrns-20160331.xml EX-101.INS 355789
8 EX-101.SCH mrns-20160331.xsd EX-101.SCH 20498
9 EX-101.CAL mrns-20160331_cal.xml EX-101.CAL 28702
10 EX-101.DEF mrns-20160331_def.xml EX-101.DEF 57822
11 EX-101.LAB mrns-20160331_lab.xml EX-101.LAB 210306
12 EX-101.PRE mrns-20160331_pre.xml EX-101.PRE 136393
Mailing Address THREE RADNOR CORPORATE CENTER 100 MATSONFORD RD, SUITE 304 RADNOR PA 19087
Business Address THREE RADNOR CORPORATE CENTER 100 MATSONFORD RD, SUITE 304 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 161612666
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences